EAPP: A Potential Drug Target and Biomarker for Various Diseases

Target Name: EAPP

NCBI ID: G55837

EAPP

EAPP: A Potential Drug Target and Biomarker for Various Diseases

EAPP (C14orf11) is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. Its primary function is to interact with the protein p21 (CDK4) and regulate the activity of the transcription factor, p53. EAPP has also been shown to play a role in the regulation of cell apoptosis, which is a natural mechanism for cell death that helps to prevent the spread of cancer.

The research on EAPP has been ongoing for several years, and there is a growing interest in it as a potential drug target or biomarker. In this article, we will discuss the current state of research on EAPP, its potential implications as a drug target, and its potential as a biomarker for the diagnosis and treatment of various diseases.

EAPP as a drug target
EAPP has been shown to be a potential drug target by several studies. One of the main reasons for its potential as a drug target is its involvement in the regulation of cell apoptosis. EAPP has been shown to play a role in the regulation of cell apoptosis by activating the p53 transcription factor and activating the genes involved in the production of pro-apoptotic proteins.

In addition, EAPP has also been shown to interact with the protein p21 (CDK4), which is a known regulator of cell growth and division. Activating the p21 transcription factor has been shown to promote the growth and proliferation of cancer cells, while inhibiting it has been shown to inhibit the growth and proliferation of cancer cells.

Another potential mechanism by which EAPP may be a drug target is its involvement in the regulation of cell adhesion. EAPP has been shown to play a role in the regulation of cell adhesion by interacting with the protein E-cadherin. This interaction between EAPP and E-cadherin has been shown to promote the formation of tight junctions and adherens junctions, which are important for the regulation of cell-cell communication and the maintenance of tissue structure.

EAPP as a biomarker
EAPP has also been shown to be a potential biomarker for the diagnosis and treatment of various diseases. One of the main advantages of EAPP as a biomarker is its ability to be easily measured and detected in various biological samples, such as blood, urine, and tissue samples.

In addition, EAPP has been shown to be expressed in a variety of tissues and cells, which makes it a potential biomarker for a wide range of diseases. For example, EAPP has been shown to be expressed in many types of cancer cells, as well as in normal tissues such as the brain and heart. This makes it a potential biomarker for the diagnosis and treatment of cancer.

Another potential application of EAPP as a biomarker is its ability to be used as a target for small molecules. Many small molecules have been shown to interact with EAPP and to promote the production of pro-apoptotic proteins. This suggests that EAPP may be a sensitive target for drugs that are designed to induce cell apoptosis.

EAPP as a potential therapeutic target
Given the potential involvement of EAPP in the regulation of cell apoptosis and its expression in various tissues, it is not surprising that there is ongoing research into its potential as a therapeutic target.

One of the main strategies being explored is the use of small molecules to inhibit the activity of EAPP and to induce cell apoptosis. Many of these small molecules have been shown to be effective in promoting the production of pro-apoptotic proteins, and it is likely that they will be effective in inhibiting the activity of EAPP as well.

Another approach being explored is the use of antibodies to target EAPP and to inhibit its

Protein Name: E2F Associated Phosphoprotein

Functions: May play an important role in the fine-tuning of both major E2F1 activities, the regulation of the cell-cycle and the induction of apoptosis. Promotes S-phase entry, and inhibits p14(ARP) expression

The "EAPP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EAPP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets